Introduction: Mechanisms of positive inotropic effects Hasso Scholz Cellular And Subcellular Mechanisms, Energy Turnover Pages: 3 - 7
Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction A. R. DennissD. A. RichardsJ. B. Uther Original Contributions Pages: 5 - 12
Adrenoceptors in myocardial regulation: concomitant contribution from both alpha- and beta-adrenoceptor stimulation to the inotropic response J. B. OsnesH. AassT. Skomedal Cellular And Subcellular Mechanisms, Energy Turnover Pages: 9 - 17
Myocardial O2 supply and consumption in early cardiac hypertrophy of renal hypertensive rabbits C. M. CiminiM. E. UpsherH. R. Weiss Original Contributions Pages: 13 - 21
Studies on the cellular mechanisms of action of positive and negative inotropic agents A. M. WatanabeF. GreenZ. Ahmad Cellular And Subcellular Mechanisms, Energy Turnover Pages: 19 - 22
Rest- and stimulation-dependent changes in exchangeable calcium content in rabbit ventricular myocardium B. Pytkowski Original Contributions Pages: 22 - 29
On the mechanism of positive inotropic effects of alpha-adrenoceptor agonists W. SchmitzC. KohlJ. Scholz Cellular And Subcellular Mechanisms, Energy Turnover Pages: 23 - 33
GTP-independent stimulation of rabbit heart adenylate cyclase by isoproterenol at physiological ATP concentrations S. E. HardingA. M. HopwoodP. Harris Original Contributions Pages: 30 - 41
Cytosolic sodium concentration regulates contractility of cardiac muscle Shey-Shing Sheu Cellular And Subcellular Mechanisms, Energy Turnover Pages: 35 - 45
Coronary collateral reserve during exercise induced ischemia in swine F. C. WhiteD. M. RothC. M. Bloor Original Contributions Pages: 42 - 54
Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart Arnold M. Katz Cellular And Subcellular Mechanisms, Energy Turnover Pages: 47 - 53
Electrophysiological interactions between carbachol and class I antiarrhythmic drugs (lidocaine, quinidine)—experimental studies in rabbit atrial myocardium H. LangenfeldC. KöhlerK. Kochsiek Original Contributions Pages: 55 - 62
Genetic and non-genetic control of myocardial calcium N. R. AlpertE. M. BlanchardM. Periasamy Cellular And Subcellular Mechanisms, Energy Turnover Pages: 55 - 66
Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound: Mechanism of action S. DattaD. K. DasJ. Klar Original Contributions Pages: 63 - 76
Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism Masao Endoh Pharmacology Of Positive Inotropic Substances Pages: 69 - 83
High-energy phosphates, myocardial contractile function and material properties after short periods of oxygen deficiency H. M. HoffmeisterR. StorfL. Seipel Original Contributions Pages: 77 - 90
Studies on the mechanism of action of the bipyridine milrinone on the heart A. E. FarahC. J. Frangakis Pharmacology Of Positive Inotropic Substances Pages: 85 - 103
Distribution pattern of α and β myosin in normal and diseased human ventricular myocardium P. BouvagnetH. MairhoferJ. J. Leger Original Contributions Pages: 91 - 102
The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia G. J. GroverW. A. Schumacher Original Contributions Pages: 103 - 110
Ca-Agonists: a new class of inotropic drugs M. BechemR. GrossM. Schramm Pharmacology Of Positive Inotropic Substances Pages: 105 - 116
Myofibrillar Ca++ activation and heart failure — Ca++ sensitization by the cardiotonic agent APP 201-533 J. W. HerzigL. H. BotelhoR. J. Solaro Pharmacology Of Positive Inotropic Substances Pages: 117 - 124
Positive inotropic stimulation in the normal and insufficient human myocardium E. ErdmannM. Böhm Pharmacology Of Positive Inotropic Substances Pages: 125 - 133
Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility? O. -E. BroddeH. -R. Zerkowski Pharmacology Of Positive Inotropic Substances Pages: 135 - 144
Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations G. HasenfussC. HolubarschHj. Just Clinical Experience With Positive Inotropic Substances Pages: 147 - 155
Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease H. PouleurC. van EyllM. F. Rousseau Clinical Experience With Positive Inotropic Substances Pages: 157 - 162
Modulation of the autonomic control of the failing heart H. M. Snow Clinical Experience With Positive Inotropic Substances Pages: 163 - 176
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation? T. MeinertzH. DrexlerHj. Just Clinical Experience With Positive Inotropic Substances Pages: 177 - 186
The use of levodopa, an oral dopamine precursor, in congestive heart failure G. BroderickS. I. Raifer Clinical Experience With Positive Inotropic Substances Pages: 187 - 190
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure Gerd HasenfussHj. Just Clinical Experience With Positive Inotropic Substances Pages: 191 - 196
Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors M. SchlepperJ. ThormannV. Mitrovic Clinical Experience With Positive Inotropic Substances Pages: 197 - 212
Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics K. Chatterjee Clinical Experience With Positive Inotropic Substances Pages: 213 - 224
Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside G. HasenfussC. HolubarschHj. Just Clinical Experience With Positive Inotropic Substances Pages: 225 - 233
Myocardial energetics: experimental and clinical studies to address its determinants and aerobic limit K. T. WeberJ. S. JanickiP. Sundram Energetic Aspects In The Intact Heart Pages: 236 - 246
Use of a conductance catheter to detect increased left ventricular inotropic state by end-systolic pressure-volume analysis G. F. LeathermanT. L. ShookW. S. Colucci Energetic Aspects In The Intact Heart Pages: 247 - 256
Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy Ch. HolubarschG. HasenfussHj. Just Energetic Aspects In The Intact Heart Pages: 257 - 265
